Results 161 to 170 of about 3,533,611 (280)

Marketing on the front line [PDF]

open access: yes, 2012
Reader, Peter
core  

Reader comments

open access: yesBaylor University Medical Center Proceedings, 2020
Walker, Mainwaring   +2 more
openaire   +3 more sources

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation

open access: yesMolecular Oncology, EarlyView.
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova   +14 more
wiley   +1 more source

Human-AI interaction in a cancer-enriched double-reading breast screening cohort: diagnostic accuracy and second-reader behavior. [PDF]

open access: yesCancer Imaging
Sossavi E   +9 more
europepmc   +1 more source

Farewell readers [PDF]

open access: yesIndian Journal of Plastic Surgery, 2014
openaire   +3 more sources

READER’S FORUM

open access: yesKorean Journal of Orthodontics, 2022
Kim, Jaehyun, Oh, Jiyoung
openaire   +2 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy